Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-01-10 @ 2:06 PM
Study NCT ID:
NCT03206151
Status:
COMPLETED
Last Update Posted:
2025-05-23
First Post:
2017-06-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer
Sponsor:
Taizhou Mabtech Pharmaceutical Co.,Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-06
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-28
First Submit QC Date:
None
Study First Post Date:
2017-07-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-19
Last Update Post Date:
2025-05-23
Last Update Post Date Type:
ACTUAL